🔗 Permalink

Inventor profile of:

David C. Myles

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2026-05-28

Top Assignees for applications by David C. Myles

The entities that hold a legal rights for patent applications filed by inventor Myles David C.:

OLEMA PHARMACEUTICALS, INC. 8 San Francisco, CA United States
PFIZER INC. 2 New York, NY United States
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 1 PHILADELPHIA, PA United States
Aurigene Oncology Limited 1 Karnataka, India

Recent patent applications by Myles David C.

David C. Myles from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28

US20260144778A1

Human necessities

REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS

#2 | 2026-04-16

US20260103461A1

Chemistry; metallurgy

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

#3 | 2026-02-26

US20260055103A1

Chemistry; metallurgy

2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE DERIVATIVES AS ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER

#4 | 2026-01-15

US20260015327A1

Chemistry; metallurgy

ACYLSULFONAMIDE KAT6A INHIBITORS

#5 | 2025-07-03

US20250214996A1

Chemistry; metallurgy

SALTS AND SOLID FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST

#6 | 2025-05-01

US20250136553A1

Chemistry; metallurgy

ACYLSULFONAMIDE KAT6A INHIBITORS

#7 | 2025-02-20

US20250059204A1

Chemistry; metallurgy

FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS

#8 | 2025-02-13

US20250049768A1

Human necessities

METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES

#9 | 2024-07-11

US20240226073A9

Human necessities

TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS

#10 | 2024-04-25

US20240131013A1

Human necessities

TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS

#11 | 2023-05-25

US20230159619A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR REGULATING IMMUNE SYSTEM ACTIVITY

#12 | 2023-04-27

US20230129598A1

Human necessities

METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES

#13 | 2023-04-06

US20230109666A2

Human necessities

REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS

#14 | 2022-11-24

US20220370421A1

Human necessities

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

#15 | 2022-08-25

US20220265616A1

Human necessities

REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS

#16 | 2021-03-04

US20210059991A1

Human necessities

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

#17 | 2019-08-15

US20190247372A1

Human necessities

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

#18 | 2018-10-11

US20180289679A1

Human necessities

Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs

#19 | 2017-12-21

US20170362210A1

Chemistry; metallurgy

ANTI-ESTROGENIC COMPOUNDS

#20 | 2016-10-27

US20160311805A1

Chemistry; metallurgy

ANTI-ESTROGENIC COMPOUNDS

#21 | 2015-07-16

US20150197506A1

Chemistry; metallurgy

NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF

#22 | 2013-07-11

US20130178445A1

Human necessities

Benzopyran compounds, compositions and uses thereof

#23 | 2011-07-14

US20110172220A1

Chemistry; metallurgy

Discodermolide analogues and methods of their use

InventorID:

335809 ⎘